Halliburton Investor Relations Retained as Counsel to EDAP TMS S.A.; Company to Begin Enhanced Shareholder Communications and Ou

Halliburton Investor Relations Retained as Counsel to EDAP TMS
S.A.; Company to Begin Enhanced Shareholder Communications and Outreach Program



DALLAS, Feb. 7  /PRNewswire/ -- EDAP TMS S.A. (NASDAQ:EDAP), has retained
Halliburton Investor Relations to assist the company in its efforts to
communicate with the investment community.

EDAP TMS S.A. develops and markets Ablatherm, the most advanced and clinically
proven choice for High Intensity Focused Ultrasound (HIFU) treatment of
localized prostate cancer. HIFU treatment is shown to be a minimally invasive
and effective treatment option with a low occurrence of side effects. The
company is also developing this technology for the treatment of certain other
types of tumors. EDAP TMS S.A. also produces and commercializes medical
equipment for treatment of urinary tract stones using Extra-corporeal Shockwave
Lithotripsy (ESWL).

Based in Dallas, Texas, Halliburton Investor Relations was formed in 1990 to
provide a superior caliber of investor relations representation to publicly
traded companies. The firm develops strategic communications programs designed
to cultivate highly targeted relationships in the financial community and
improve the visibility of successful public companies to investors. For more
information, visit the company's Web site at http://www.halliburtonir.com/ .

For more information on the Company, contact Halliburton Investor Relations by
phone at 972-458-8000 or see the Investor Relations Section at:
http://www.edap-tms.com/ .

This press release contains, in addition to historical information,
forward-looking statements that involve risks and uncertainties. These include
statements regarding the Company's growth and expansion plans. Such statements
are based on management's current expectations and are subject to a number of
uncertainties and risks that could cause actual results to differ materially
from those described in the forward-looking statements. Factors that may cause
such a difference include, but are not limited to, those described in the
Company's filings with the Securities and Exchange Commission. 

DATASOURCE: Halliburton Investor Relations



CONTACT:  Matt Kreps, or Geralyn DeBusk, both of Halliburton Investor

Relations, [phone]



Web site:  http://www.halliburtonir.com/

http://www.edap-tms.com/ 



Company News On-Call:  http://www.prnewswire.com/comp/133897.html 

Copyright